Dr. Christine Munz becomes CEO at Eppendorf

Dr. Wilhelm Plüster completes term in office as planned

03-Sep-2024

The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the company as planned.

Eppendorf

Dr. Christine Munz

“We are very pleased that we were able to win Dr. Munz for Eppendorf and the CEO position,” said Philipp von Loeper, the Chairman of the Supervisory Board at Eppendorf SE. “On behalf of the entire Supervisory Board, I would also like to thank Dr. Plüster for his tremendous commitment to the company with which he has worked as CEO in the past few months. After serving more than 10 years on the Management Board of Eppendorf, he demonstrated once again his enormous dedication to the company. We are really pleased that he will remain at Eppendorf and assume another responsible position within the company.”

With Dr. Christine Munz Eppendorf will have a strong international experienced CEO, said von Loeper and added: “She is a proven and highly skilled manager with many years of experience in the life science industry. Working together with the global management team, Dr. Munz will continue to drive forward Eppendorf’s successful activities and expand them in a targeted manner.”

Other news from the department people

Most read news

More news from our other portals

All autoclave manufacturers at a glance

Last viewed contents

Jung Foundation honours cutting-edge research: 4 prizes for medical breakthroughs - Their research has the potential to decisively transform the medicine of tomorrow, or has already done so

Jung Foundation honours cutting-edge research: 4 prizes for medical breakthroughs - Their research has the potential to decisively transform the medicine of tomorrow, or has already done so

Leadership change at Köttermann B.V. in the Netherlands

Leadership change at Köttermann B.V. in the Netherlands

1.2 million US dollar award honors pioneering work in cryo-electron tomography - Wolfgang Baumeister receives prestigious Shaw Prize

1.2 million US dollar award honors pioneering work in cryo-electron tomography - Wolfgang Baumeister receives prestigious Shaw Prize

Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer

Leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer

Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Refeyn Announces Leadership Transition - Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors

Joachim Kreuzburg, Former CEO of Sartorius, Joins Cube Biotech’s Board of Directors

New high-tech startup developing smart contact lenses for glaucoma diagnosis and management

New high-tech startup developing smart contact lenses for glaucoma diagnosis and management

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform - A revolution in drug discovery thanks to a new chat assistant?

Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform - A revolution in drug discovery thanks to a new chat assistant?

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”

Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research

Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need